keyword
https://read.qxmd.com/read/35901577/trajectories-of-cognitive-and-physical-performance-after-accidental-falls-in-nursing-home-residents-a-prospective-study
#21
JOURNAL ARTICLE
Caterina Trevisan, Marianna Noale, Alessandra Imoscopi, Chiara Bigolaro, Cosetta Derni, Elena Agio, Sara Dal Ben, Marco Ceccato, Federica Tono, Stefania Maggi, Anna-Karin Welmer, Giuseppe Sergi
This prospective study evaluated cognitive and physical trajectories of nursing home (NH) residents after fall occurrence and their predictors. In 167 residents aged ≥60, we considered the closest pre-fall assessment and up to the first three post-fall assessments of cognitive and physical functions performed through Mini-Mental State Examination (MMSE) and Tinetti tests. Mixture models identified three post-fall cognitive and physical trajectories: stability, slow decline, and rapid decline. At logistic regression, older age, fewer informal visits, and falls within one month from institutionalization increased the probability of experiencing a decline in MMSE and Tinetti scores...
September 2022: Geriatric Nursing
https://read.qxmd.com/read/35812532/hospital-agios-dimitrios-the-general-public-hospital-of-thessaloniki
#22
REVIEW
Spyros N Michaleas, Gregory Tsoucalas, Markos Sgantzos, Georgios Androutsos, Marianna Karamanou
The purpose of this article is to highlight the history of Hospital Agios Dimitrios, the General Hospital of Thessaloniki. During the early 20th century, many refugees settled in the Greek city of Thessaloniki. To address the growing public health needs of the city's inhabitants, the Greek government established a health agency to offer medical care and respond to infectious disease outbreaks and epidemics. This initiative resulted in the construction or renovation of various hospitals. The Hospital Agios Dimitrios in Thessaloniki was completed in 1903...
June 2022: Curēus
https://read.qxmd.com/read/35729281/design-synthesis-and-characterization-of-novel-eco-friendly-chitosan-agio-3-bionanocomposite-and-study-its-antibacterial-activity
#23
JOURNAL ARTICLE
Mohammad Ali Ahghari, Mohammad Reza Ahghari, Maryam Kamalzare, Ali Maleki
This work reports a facile and green approach to preparing AgIO3 nanoparticles decorated with chitosan (chitosan-AgIO3 ). The bionanocomposite was fully characterized by Fourier transform infrared (FTIR), scanning electron microscopy (SEM) images, energy-dispersive X-ray spectroscopy (EDX), and X-ray diffraction analysis (XRD). The antibacterial effect of chitosan-AgIO3 bionanocomposite was investigated for Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus saprophyticus, Escherichia coli, and Staphylococcus aureus as pathogen microorganisms via the plate count method, disk diffusion method, and optical density (OD) measurements...
June 21, 2022: Scientific Reports
https://read.qxmd.com/read/35708343/costs-per-patient-achieving-remission-with-venetoclax-based-combinations-in-newly-diagnosed-patients-with-acute-myeloid-leukemia-ineligible-for-intensive-induction-chemotherapy
#24
JOURNAL ARTICLE
Michelle Choi, Jinlin Song, Cat N Bui, Esprit Ma, Xinglei Chai, Lei Yin, Keith A Betts, Tatyana Kapustyan, Melissa Montez, Thomas William LeBlanc
BACKGROUND: Venetoclax, in combination with azacitidine, decitabine, or low-dose cytarabine (LDAC), received confirmatory approval in 2020 by the US Food and Drug Administration for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients aged 75 years or older or who are ineligible for intensive induction chemotherapy. The economic value associated with response to venetoclax combinations compared with other treatments for this patient population has not been comprehensively evaluated. OBJECTIVE: To assess the cost per patient achieving remission with venetoclax combination therapies, compared with other therapies for newly diagnosed patients with AML who are ineligible for intensive induction chemotherapy, from a US third-party payer perspective...
September 2022: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/35443108/ivosidenib-and-azacitidine-in-idh1-mutated-acute-myeloid-leukemia
#25
RANDOMIZED CONTROLLED TRIAL
Pau Montesinos, Christian Recher, Susana Vives, Ewa Zarzycka, Jianxiang Wang, Giambattista Bertani, Michael Heuser, Rodrigo T Calado, Andre C Schuh, Su-Peng Yeh, Scott R Daigle, Jianan Hui, Shuchi S Pandya, Diego A Gianolio, Stephane de Botton, Hartmut Döhner
BACKGROUND: The combination of ivosidenib - an inhibitor of mutant isocitrate dehydrogenase 1 (IDH1) - and azacitidine showed encouraging clinical activity in a phase 1b trial involving patients with newly diagnosed IDH1 -mutated acute myeloid leukemia. METHODS: In this phase 3 trial, we randomly assigned patients with newly diagnosed IDH1 -mutated acute myeloid leukemia who were ineligible for intensive induction chemotherapy to receive oral ivosidenib (500 mg once daily) and subcutaneous or intravenous azacitidine (75 mg per square meter of body-surface area for 7 days in 28-day cycles) or to receive matched placebo and azacitidine...
April 21, 2022: New England Journal of Medicine
https://read.qxmd.com/read/35417638/mitapivat-versus-placebo-for-pyruvate-kinase-deficiency
#26
RANDOMIZED CONTROLLED TRIAL
Hanny Al-Samkari, Frédéric Galactéros, Andreas Glenthøj, Jennifer A Rothman, Oliver Andres, Rachael F Grace, Marta Morado-Arias, D Mark Layton, Koichi Onodera, Madeleine Verhovsek, Wilma Barcellini, Satheesh Chonat, Malia P Judge, Erin Zagadailov, Rengyi Xu, Peter Hawkins, Vanessa Beynon, Sarah Gheuens, Eduard J van Beers
BACKGROUND: Pyruvate kinase deficiency is a rare, hereditary, chronic condition that is associated with hemolytic anemia. In a phase 2 study, mitapivat, an oral, first-in-class activator of erythrocyte pyruvate kinase, increased the hemoglobin level in patients with pyruvate kinase deficiency. METHODS: In this global, phase 3, randomized, placebo-controlled trial, we evaluated the efficacy and safety of mitapivat in adults with pyruvate kinase deficiency who were not receiving regular red-cell transfusions...
April 14, 2022: New England Journal of Medicine
https://read.qxmd.com/read/35397465/core-shell-structured-z-scheme-ag-2-s-agio-3-composites-for-photocatalytic-organic-pollutants-degradation
#27
JOURNAL ARTICLE
Haojia Ding, Linping Bao, Yao Su, Yuqin Li, Guodong Xu, Chunhui Dai, Chao Zeng
Constructing direct Z-scheme system is a promising strategy to boost the photocatalytic performance for pollution waters restoration, but it is of great challenge because of the requirement of appropriately staggered energy band alignment and intimate interfacial interaction between semiconductors. Herein, a class of core-shell structured Ag2 S-AgIO3 Z-scheme heterostructure photocatalysts are designed and developed. Ag2 S is generated by the in-situ ion exchange reaction and anchored on the surface of AgIO3 , so the intimate interface between AgIO3 and Ag2 S is realized...
April 6, 2022: Journal of Environmental Management
https://read.qxmd.com/read/35333017/the-greek-hospital-and-pharmacies-of-smyrna-1723-1922
#28
JOURNAL ARTICLE
Spyros N Michaleas, Theodoros N Sergentanis, Aristeidis Diamantis, Krystallenia Alexandraki, Lazaros Vladimiros
https://doi.org/10.31952/amha.19.2.5 From the mid-18th century to the mid-20th century, Greek doctors in Smyrna collaborated with pharmacists, churches, and the city's Greek Orthodox community to create a state of-the-art health network and charitable foundation to serve physical and mental health needs of the local community. At Graekikon Nosokomion o Agios Haralampos (Greek Saint Charalampos Hospital), or the Greek Hospital, every citizen, regardless of origin, language, religion, or economic status, had access to the most appropriate medical and pharmaceutical care...
December 14, 2021: Acta Medico-historica Adriatica: AMHA
https://read.qxmd.com/read/35090849/designing-z-scheme-agio-4-nanorod-embedded-with-bi-2-s-3-nanoflakes-for-expeditious-visible-light-photodegradation-of-congo-red-and-rhodamine-b
#29
JOURNAL ARTICLE
S Kokilavani, Asad Syed, Abdallah M Elgorban, Ali H Bahkali, Hind A Al-Shwaiman, Rajender S Varma, Arunava Das, S Sudheer Khan
The present study describes the enhanced photodegradation of organic pollutant dyes, congo red (CR) and rhodamine B (RhB) dyes under visible light irradiation. AgIO4 nanorods decorated on Bi2 S3 nanoflakes in various proportions were synthesized via sono-chemical route wherein the deposition of varying amounts of AgIO4 on Bi2 S3 plays a pivotal role in improving the photodegradation ability. The characterization of the as-synthesized nanohybrids was assessed by XRD, UV-vis DRS, PL, EIS, ESR, FT-IR, XPS, HR-TEM, FE-SEM, N2 adsorption and desorption techniques...
January 25, 2022: Chemosphere
https://read.qxmd.com/read/34701799/survival-outcomes-and-symptom-benefit-from-palliative-radiotherapy-in-breast-cancer-patients-with-leptomeningeal-disease
#30
JOURNAL ARTICLE
J Takayesu, E Sapir, J Xie, Y Sun, A Morikawa, L Junck, D Leung, Y Umemura, J Heth, W Al-Holou, D R Wahl, T S Lawrence, C Mayo, J A Hayman, M M Kim
PURPOSE/OBJECTIVE(S): The benefit of radiotherapy (RT) in poor-prognosis patients with leptomeningeal disease (LMD) is not well characterized. This study assessed the overall survival (OS) and clinical improvement of a largely symptomatic cohort of breast cancer patients with LMD, to identify patient subsets most likely to benefit from palliative RT. MATERIALS/METHODS: Patients with breast cancer and classic radiographic LMD (36% cytology-confirmed) treated with palliative whole brain and/or partial spine RT between 2000-2020 at a single academic institution were included in this retrospective analysis...
November 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/34701756/concurrent-immunotherapy-with-stereotactic-radiation-for-brain-metastases-is-not-associated-with-increased-rates-of-radionecrosis
#31
JOURNAL ARTICLE
S G Allen, J J Waninger, S R Birer, S Journey, J Skvarce, D R Wahl, T S Lawrence, J A Hayman, M M Kim, M Green
PURPOSE/OBJECTIVE(S): Early concerns were raised about higher rates of radionecrosis (RN) with concurrent use of immune checkpoint inhibition (ICI) and stereotactic radiotherapy (SRT) for brain metastases (BM). We sought to clarify if this same concern translated to linear accelerator-based SRT for BM. MATERIALS/METHODS: We retrospectively reviewed cases of SRT delivered at a single institution for BM (2004-2019). In total, 251 patients and 723 courses of treatment were analyzed on a per-treatment basis for any grade RN...
November 1, 2021: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/34653152/ultrafast-single-photon-detection-at-high-repetition-rates-based-on-optical-kerr-gates-under-focusing-erratum
#32
JOURNAL ARTICLE
Abdul-Hamid Fattah, Assegid Mengistu Flatae, Amr Farrag, Mario Agio
Two typos are corrected, and the linear refractive index n is removed from the expressions of the phase shift in Opt. Lett.46, 560 (2021)OPLEDP0146-959210.1364/OL.414895. The removal of n reduces the gate efficiency, but it does not affect the general findings. Here, we present the corrected equations and the corresponding new numerical results, showing that increasing the pulse energy from 1.8 nJ to 4 nJ leads to nearly the same results of Opt. Lett.46, 560 (2021)OPLEDP0146-959210.1364/OL.414895.
October 15, 2021: Optics Letters
https://read.qxmd.com/read/34595955/cost-effectiveness-of-gilteritinib-for-relapsed-refractory-flt3-mut-acute-myeloid-leukemia
#33
JOURNAL ARTICLE
Bhavik J Pandya, Cynthia Z Qi, Andy Garnham, Hongbo Yang, Manasee V Shah, Amer M Zeidan
BACKGROUND: Patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and confirmed feline McDonough sarcoma (FMS)-like tyrosine kinase 3 gene mutations ( FLT3 mut+ ) have a poor prognosis and limited effective treatment options. Gilteritinib is the first targeted therapy approved in the United States and Europe for R/R FLT3 mut+ AML with significantly improved efficacy compared with existing treatments. OBJECTIVE: To evaluate gilteritinib against salvage chemotherapy (SC) and best supportive care (BSC) over a lifetime horizon among adult patients with R/R FLT3 mut+ AML from a US third-party payer's perspective...
October 2021: Journal of Managed Care & Specialty Pharmacy
https://read.qxmd.com/read/34300538/energy-efficient-swipt-based-mobile-edge-computing-framework-for-wsn-assisted-iot
#34
JOURNAL ARTICLE
Fangni Chen, Anding Wang, Yu Zhang, Zhengwei Ni, Jingyu Hua
With the increasing deployment of IoT devices and applications, a large number of devices that can sense and monitor the environment in IoT network are needed. This trend also brings great challenges, such as data explosion and energy insufficiency. This paper proposes a system that integrates mobile edge computing (MEC) technology and simultaneous wireless information and power transfer (SWIPT) technology to improve the service supply capability of WSN-assisted IoT applications. A novel optimization problem is formulated to minimize the total system energy consumption under the constraints of data transmission rate and transmitting power requirements by jointly considering power allocation, CPU frequency, offloading weight factor and energy harvest weight factor...
July 14, 2021: Sensors
https://read.qxmd.com/read/33528409/ultrafast-single-photon-detection-at-high-repetition-rates-based-on-optical-kerr-gates-under-focusing
#35
JOURNAL ARTICLE
Abdul-Hamid Fattah, Assegid Mengistu Flatae, Amr Farrag, Mario Agio
The ultrafast detection of single photons is currently restricted by the limited time resolution (a few picoseconds) of the available single-photon detectors. Optical gates offer a faster time resolution, but so far they have been applied mostly to ensembles of emitters. Here, we demonstrate through a semi-analytical model that the ultrafast time-resolved detection of single quantum emitters can be possible using an optical Kerr shutter at gigahertz rates under focused illumination. This technique provides sub-picosecond time resolution, while keeping a gate efficiency at around 85%...
February 1, 2021: Optics Letters
https://read.qxmd.com/read/33504578/agios-exits-oncology
#36
(no author information available yet)
Agios Pharmaceuticals, the company behind the only two IDH-targeted drugs on the market and a brain-penetrant IDH inhibitor in late-stage testing for glioma, announced plans to sell its oncology business to Servier for up to $2 billion plus royalties.
March 2021: Cancer Discovery
https://read.qxmd.com/read/33405129/determination-of-heavy-metals-in-the-territory-of-contaminated-areas-of-greece-and-their-restoration-through-hyperaccumulators
#37
REVIEW
Georgios Charvalas, Alexandra D Solomou, Kyriakos D Giannoulis, Elpiniki Skoufogianni, Dimitrios Bartzialis, Christina Emmanouil, Nicholaos G Danalatos
Phytoremediation is an effective technique for the processing of contaminated soil and for sequestering environmental contaminants such as heavy metals. This kind of pollution is ubiquitous in mines and similar excavation sites. This mini-review aims to provide an overview of the alternative forms of restoring contaminated soils (phytoremediation) highlighting the areas of Kozani (Agios Dimitrios) and Chalkidiki (Stratoni) in Greece characterized by exorbitant metallurgical activities. Firstly, a literature search in databases such as ScienceDirect, SciFinder, PubMed, Google Scholar, and Scopus was conducted, using the following keywords to identify relevant articles: "utilization", "plants", "phytoremediation", "sustainability", "environment", and "restoration"...
January 6, 2021: Environmental Science and Pollution Research International
https://read.qxmd.com/read/33325888/focused-gaussian-beam-in-the-paraxial-approximation
#38
JOURNAL ARTICLE
Ankur Das, Navid Soltani, Mario Agio
A focused Gaussian beam represents a case of highly practical importance in many areas of optics and photonics. We derive analytical expressions for a focused Gaussian beam in the paraxial approximation, considering an arbitrary lens filling factor. We discuss the role of higher-order Bessel functions of the first kind in defining the electric field in the focal region.
December 15, 2020: Optics Letters
https://read.qxmd.com/read/33302739/susan-pandya-on-investigational-treatment-approaches-to-cholangiocarcinoma
#39
JOURNAL ARTICLE
Susan Pandya
No abstract text is available yet for this article.
December 10, 2020: Expert Opinion on Investigational Drugs
https://read.qxmd.com/read/32482930/laxative-activity-of-the-hot-water-extract-mixture-of-hovenia-dulcis-thunb-and-phyllostachys-pubescens-mazel-in-chronic-constipation-model-sd-rats
#40
JOURNAL ARTICLE
Kyo-Nyeo Oh, Yujin Kim, Eun Jin Choi, Hyunmi Lee, Ji Ae Hong, Miri Kim, Dool-Ri Oh, Myung-A Jung, Ro-Dong Park, Seong-Il Kim, Ju-Seon Yong, Hui-Seop Lee, SangOh Ban, Chul-Yung Choi
This study examined the laxative effects of hot-water extracts of Hovenia dulcis Thunb. (HD), Phyllostachys pubescens Mazel (PM), and a 2:8 mixture of both (HP) in two chronic constipation models. For the loperamide-induced constipation model, animals were divided into an untreated group, negative control group (loperamide 4 mg/kg), positive control group (bisacodyl 4 mg/kg) group, and six treatment groups (HP 100 or 400, HD 50 or 100, and PM 100 or 400 mg/kg). For the lowfiber diet-induced constipation model, animals were divided into an untreated group (normal diet), negative control group (low-fiber diet), positive control group (Agio granule, 620 mg/kg), and the same treatment groups...
May 28, 2020: Journal of Microbiology and Biotechnology
keyword
keyword
38092
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.